SCHEMBL3601601

SCHEMBL3601601

Oc1ccc(-c2cc(-c3ccccn3)nc(-c3ccccn3)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.63
RAB9A P51151 2/20 0.63
CCR1 P32246 3/20 0.55
CCR5 P51681 3/20 0.55
CCR8 P51685 3/20 0.55
KDM4E B2RXH2 4/20 0.53
LMNA P02545 3/20 0.53
TP53 P04637 2/20 0.53
ALOX15 P16050 2/20 0.53
HTT P42858 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ALPL P05186 1/20 0.53
HSP90AA1 P07900 1/20 0.53
ALPI P09923 1/20 0.53
ALPG P10696 1/20 0.53
MAPK1 P28482 1/20 0.53
POLB P06746 2/20 0.52
ALDH1A1 P00352 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29660049 0.91 CCR1 (0.64) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL2007559 0.91 CCR1 (0.64) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL13311187 0.91 CCR1 (0.64) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL18489879 0.89 CCR1 (0.62) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL6130692 0.87 CCR1 (0.56) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL2542485 0.87 CCR1 (0.60) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL4951059 0.87 KDM4E (0.70) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL18680017 0.85 CCR1 (0.58) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL17953009 0.85 CCR1 (0.63) NPC1RAB9ACCR1CCR5CCR8
SCHEMBL3588835 0.85 CCR1 (0.62) NPC1RAB9ACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214296-B Preparation method and application of one-dimensional dysprosium chain magnetic complex expanded by hydroxyl 天津师范大学 2022-08-19 CN claimed
CN-112409389-B Preparation method and application of gelator based on terpyridine and oxynitride 河北科技大学 2022-08-12 CN claimed
CN-113480562-B One-dimensional dysprosium chain magnetic complex with two-step relaxation, and preparation method and application thereof 天津师范大学 2022-08-05 CN claimed
CN-113480562-A One-dimensional dysprosium chain magnetic complex with two-step relaxation, and preparation method and application thereof 天津师范大学 2021-10-08 CN claimed
CN-113214296-A Preparation method and application of one-dimensional dysprosium chain magnetic complex expanded by hydroxyl 天津师范大学 2021-08-06 CN claimed
CN-103336042-B Terpyridine derivative modified electrode for electrochemically detecting copper ions and preparation method of terpyridine derivative modified electrode UNIV XINYU 2015-05-13 CN claimed
CN-103336042-A Terpyridine derivative modified electrode for electrochemically detecting copper ions and preparation method of terpyridine derivative modified electrode UNIV XINYU 2013-10-02 CN claimed
EP-4634168-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS Johnson & Johnson Vision Care, Inc. (US) 2025-10-22 EP disclosed
CN-118772863-A Preparation method of high-temperature organic blue phosphorescent material 湘潭大学 2024-10-15 CN disclosed
US-20240228466-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS JOHNSON & JOHNSON VISION CARE, INC. 2024-07-11 US disclosed
US-20240228466-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS JOHNSON & JOHNSON VISION CARE, INC. 2024-07-11 US disclosed
WO-2024127114-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-06-20 WO disclosed
WO-2024127114-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-06-20 WO disclosed
CN-103336042-B Terpyridine derivative modified electrode for electrochemically detecting copper ions and preparation method of terpyridine derivative modified electrode UNIV XINYU 2015-05-13 CN disclosed
CN-103336042-A Terpyridine derivative modified electrode for electrochemically detecting copper ions and preparation method of terpyridine derivative modified electrode UNIV XINYU 2013-10-02 CN disclosed
US-7811675-B2 Electroluminescent metallo-supramolecules with terpyridine-based groups THE UNIVERSITY OF HONG KONG (CN) 2010-10-12 US disclosed
EP-1558669-A4 ELECTROLUMINESCENT METALLO-SUPRAMOLECULES WITH TERPYRIDINE-BASED GROUPS UNIV HONG KONG (CN) 2007-06-06 EP disclosed
EP-1558669-A1 ELECTROLUMINESCENT METALLO-SUPRAMOLECULES WITH TERPYRIDINE-BASED GROUPS The University of Hong Kong (CN) 2005-08-03 EP disclosed
WO-2004041913-A1 ELECTROLUMINESCENT METALLO-SUPRAMOLECULES WITH TERPYRIDINE-BASED GROUPS THE UNIVERSITY OF HONG KONG (CN) 2004-05-21 WO disclosed
US-20040086744-A1 Electroluminescent metallo-supramolecules with terpyridine-based groups VERSITECH LIMITED (CN) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228466-A1 TRANSITION METAL COMPLEXES AS VISIBLE LIGHT ABSORBERS UACA, C1R, MSH2 NPC1 3960/4885RAB9A 2328/4885CCR1 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.